Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory counterregulatory hormone concentrations

World Journal of Gastroenterology

Volumn 9, Issue 8, 2003, Pages 1824-1827

  Yu, Wen Kui ^a   Li, Wei Qin ^a   Li, Ning ^a   Li, Jie Shou ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCAGON; GLUCOSE; HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE TOLERANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; RADIOIMMUNOASSAY; SEPSIS;

EID: 0041926756     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i8.1824     Document Type: Article

References (34)

1. Wu XN. Current concept of pathogenesis of severe acute pancreatitis. World J Gastroenterol 2000; 6: 32-36
2. Netea MG, Van Der Meer JW, Kullberg BJ. Sepsis-theory and therapies. N Engl J Med 2003; 348: 1600-1602
3. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002; 8: 961-965
4. Douglas RG, Shaw JH. Metabolic response to sepsis and trauma. Br J Surg 1989; 76: 115
5. Wray CJ, Mammen JM, Hasselgren PO. Catabolic response to stress and potential benefits of nutrition support. Nutrition 2002; 18: 971-977
6. Wu XN. Treatment revisited and factors affecting prognosis of severe acute pancreatitis. World J Gastroenterol 2000; 6: 663-665
7. Chen QP. Enteral nutrition and acute pancreatitis. World J Gastroenterol 2001; 7: 185-192
8. Mesotten D, Van Den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs 2003; 63: 625-636
9. Hirsch IB. In-patient hyperglycemia - Are we ready to treat it yet? J Clin Endocrinol Metab 2002; 87: 975-977
10. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001; 103: 1618-1623
11. Mizock BA. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 553-551
12. Vasa FR, Molitch ME. Endocrine problems in the chronically critically ill patient. Clin Chest Med 2001; 22: 193-208
13. Alexiewicz JM, Kumar D, Smogorzewski M, Massry SG. Elevated cytosolic calcium and impaired proliferation of B lymphocytes in type II diabetes mellitus. Am J Kidney Dis 1997; 30: 98-104
14. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997; 83: 1566-1574
15. Reinhold D, Anosorge S, Scheeicher ED. Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 Production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res 1996; 28: 267-270
16. Gregory R, McElveen J, Tattersall RB, Todd I. The effects of 3-hydroxybutyrate and glucose on human T cell responses to Candida albicans. FEMS Immunol Med Microbiol 1993; 7: 315-320
17. Moises RS, Heidenreich KA. Glucose regulates expression of Gi-proteins in cultured BC3H-1 myocytes. Biochem Biophys Res Commun 1992; 182: 1193-1200
18. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874
20. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg 1983; 70: 29-31
21. Shamoon H, Hendler R, Sherwin RS. Altered responsiveness to cortisol, eipinephrine and glucagon in insulin-infused juvenile-onset diabetes A mechanism for diabetic instability. Diabetes 1980; 29: 284-291
22. Zhang GL, Wang YH, Teng HL, Lin ZB. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World J Gastroenterol 2001; 7: 331-334
23. Webber J. Abnormalities in glucose metabolism and their relevance to nutrition support in the critically ill. Curr Opin Clin Nutr Metb Care 1998; 1: 191-194
24. Wang P, Li N, Li JS, Li WQ. The role of endotoxin, TNF-α, and IL-6 in inducing the state of growth hormone insensitivity. World J Gastroenterol 2002; 8: 531-536
25. Chang HR, Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parenter Enteral Nutr 1998; 22: 156-166
26. Wolfe RR. Substrate utilization/insulin resistance in sepsis/trauma. Balliere's Clin Endocrinol Metab 1997; 11: 645-657
27. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981; 240: E630-E639
28. Tappy L, Schwarz JM, Schneiter P, Cayeux C, Revelly JP, Fagerquist CK, Jequier E, Chiolero R. Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients. Crit Care Med 1998; 26: 860-867
29. Saeed M, Carlson GL, Little RA, Irving MH. Selective impairment of glucose storage in human sepsis. Br J Surg 1999; 86: 813-821
30. Soop M, Duxbury H, Agwunobi AO, Gibson SM, Hopkins SJ, Childs C, Cooper RG, Maycock P, Little RA, Carlson GL. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab 2002; 282: E1276-E1285
31. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996; 45: 954-959
32. Pampfer S, Vanderheyden I, De Hertogh R. Increased synthesis of tumor necrosis factor-alpha in uterine explants from pregnant diabetic rats and in primary cultures of uterine cells in high glucose. Diabetes 1997; 46: 1214-1224
33. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE. Glucose-induced release of tumor necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 2001; 18: 921-927
34. Morohoshi M, Fujisawa K, Uchimura I, Numano F. The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann N Y Acad Sci 1995; 748: 562-570